Incyte Corporation focuses on the discovery, development, and commercialization of proprietary therapeutics in oncology in the United States and internationally. The company was founded in 1991 and is based in Wilmington, Delaware.
These five high yield drug stocks pay dividends with attractive yields, and also are undervalued. And as a result, these stocks offer good upside potential to investors. As a group, they are cheap. Yet, they have solid earnings that cover their dividends, plus good growth prospects.I wanted to find these high-yield drug stocks since there is a lot of news out there about pharmaceutical companies that are trying to find a vaccine. I figured some of these larger drug companies can be both innovative and also have a diversified level of income.This helps the pharmaceutical company satisfy the return objectives of its existing investors. However, they also offer enough growth prospects to provide upside potential for new investors.InvestorPlace - Stock Market News, Stock Advice & Trading Ti...
Incyte Inc. is in a cutting-edge industry and its shares are poised for an upside breakout. Let's check out the charts for a technical strategy that makes sense. In the daily bar chart of INCY, below, we can see some rapid swings.
WILMINGTON, Del.--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) announced today that it has scheduled its second quarter financial results conference call and webcast for 8:00 a.m. ET on Tuesday, August 4, 2020. The schedule for the press release and conference call/webcast is as follows: Q2 2020 Press Release: August 4, 2020 at 7:00 a.m. ET Q2 2020 Conference Call: August 4, 2020 at 8:00 a.m. ET Domestic Dial-In Number: 877-407-3042 International Dial-In Number: 201-389-0864 Conference ID Numb